Most Popular
Advertising
Videos & Images
Fun Stuff
Content Section
Booking Portal
News Headlines
101 times read : Adjust font size: 
 |
RTT News - Kuvan tablets, the first specific drug therapy approved for the treatment of phenylketonuria, is co-developed in partnership with Merck Serono, a division of Merck KGaA, Darmstadt, Germany. Phenylketonuria is a genetic disorder in which the body ...
Read this article...
Comments (0 posted)
